Verrica Pharmaceuticals Inc. Made Headway
Verrica Pharmaceuticals Inc. (VRCA:NASDAQ) soared at $1.45, representing a gain of 30.6%. On Thu, Oct 03, 2024, VRCA:NASDAQ touched a New 2-Week Intraday Low of $1.1. The stock appeared on our News Catalysts scanner on Wed, Oct 02, 2024 at 10:16 AM in the 'MISCELLANEOUS' category. From Thu, Sep 19, 2024, the stock recorded 40.00% Up Days and 18.18% Green Days
About Verrica Pharmaceuticals Inc. (VRCA:NASDAQ)
Verrica Pharmaceuticals Inc a clinical-stage medical dermatology company focused on identifying, developing and commercializing innovative pharmaceutical products for the treatment of skin diseases with significant unmet needs.
Top 10 Gainers:
- Power REIT (PW:NYSEMKT), 99.65%
- Movella Holdings Inc Com (MVLA:NASDAQ), 80.65%
- EVgo Inc. (EVGO:NASDAQ), 60.81%
- Elevai Labs Inc. (ELAB:NASDAQ), 54.93%
- Graphex Group Limited American Depositary Shares each American Depositary Share representing 20 (GRFX:NYSEMKT), 51.55%
- Stem Inc. Class A (STEM:NYSE), 45.23%
- Theriva Biologics Inc Com Par $.001 (TOVX:NYSEMKT), 44.35%
- Professional Diversity Network, Inc. (IPDN:NASDAQ), 35.57%
- AMTD Digital Inc. American Depositary Shares (every five of which represent two Class A) (HKD:NYSE), 33.5%
- Verrica Pharmaceuticals Inc. (VRCA:NASDAQ), 30.63%